Home/Filings/4/0001209191-18-002556
4//SEC Filing

WRIGHT TIMOTHY MICHAEL 4

Accession 0001209191-18-002556

CIK 0001505512other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 6:58 PM ET

Size

5.4 KB

Accession

0001209191-18-002556

Insider Transaction Report

Form 4
Period: 2018-01-05
WRIGHT TIMOTHY MICHAEL
Chief R & D Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2018-01-05+500,000500,000 total
    Exercise: $1.24Exp: 2028-01-04Common Stock (500,000 underlying)
Footnotes (1)
  • [F1]The option will vest in forty-eight equal monthly installments, such that the option will be fully vested four years from the date of grant, subject to the Reporting Person's continuous service to us.

Issuer

Regulus Therapeutics Inc.

CIK 0001505512

Entity typeother

Related Parties

1
  • filerCIK 0001686178

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 6:58 PM ET
Size
5.4 KB